Pulsed Field Ablation-Based Pulmonary Vein Isolation Using a Simplified Single-Access Single-Catheter Approach ― The Fast and Furious PFA Study

Background: Pulsed field ablation (PFA) is a non-thermal energy source with promising safety and efficacy advantages. We aimed to develop a convenient, safe, effective and fast method of pulmonary vein isolation (PVI) utilizing a penta-spline PFA catheter via a single femoral vein and a venous closu...

Full description

Saved in:
Bibliographic Details
Published inCirculation Journal Vol. 87; no. 12; pp. 1722 - 1726
Main Authors Vogler, Julia, Kuck, Karl-Heinz, Tilz, Roland R., Popescu, Sorin Ștefan, Kirstein, Bettina, Eitel, Charlotte, Phan, Huong-Lan, Lopez, Lisbeth Delgado, Hatahet, Sascha, Heeger, Christian-H., Große, Niels, Subin, Behnam
Format Journal Article
LanguageEnglish
Published Japan The Japanese Circulation Society 24.11.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background: Pulsed field ablation (PFA) is a non-thermal energy source with promising safety and efficacy advantages. We aimed to develop a convenient, safe, effective and fast method of pulmonary vein isolation (PVI) utilizing a penta-spline PFA catheter via a single femoral vein and a venous closure system.Methods and Results: Consecutive patients (n=50; mean age: 63.6±10.7 years, 38% female) presenting with AF (paroxysmal AF: 56%) underwent first-time PVI via PFA. A single ultrasound-guided femoral vein puncture and a single transseptal puncture were used. After PVI using the penta-spline PFA catheter, extra pulse trains were added to the posterior wall for wide antral circumferential ablation. A venous closure system was used and a Donati suture was performed. The pressure bandage was removed after 1 h. A total of 196 PVs were identified and isolated with PFA only. The mean procedural time was 27.4±6.6 min, and the mean dwelling time was 14.4±5.5 min. Time to ambulation was 3.3±3.1 h. No severe complications occurred. During a mean follow-up of 6.5±2.1 months, 41/50 patients (82%) remained in sinus rhythm.Conclusions: The combination of a single venous puncture, single transseptal puncture approach using PFA and vascular closure device resulted in a 100% rate of acute PVI and an extraordinarily fast procedure and time to ambulation. The rate of periprocedural complications was low.
AbstractList Background: Pulsed field ablation (PFA) is a non-thermal energy source with promising safety and efficacy advantages. We aimed to develop a convenient, safe, effective and fast method of pulmonary vein isolation (PVI) utilizing a penta-spline PFA catheter via a single femoral vein and a venous closure system.Methods and Results: Consecutive patients (n=50; mean age: 63.6±10.7 years, 38% female) presenting with AF (paroxysmal AF: 56%) underwent first-time PVI via PFA. A single ultrasound-guided femoral vein puncture and a single transseptal puncture were used. After PVI using the penta-spline PFA catheter, extra pulse trains were added to the posterior wall for wide antral circumferential ablation. A venous closure system was used and a Donati suture was performed. The pressure bandage was removed after 1 h. A total of 196 PVs were identified and isolated with PFA only. The mean procedural time was 27.4±6.6 min, and the mean dwelling time was 14.4±5.5 min. Time to ambulation was 3.3±3.1 h. No severe complications occurred. During a mean follow-up of 6.5±2.1 months, 41/50 patients (82%) remained in sinus rhythm.Conclusions: The combination of a single venous puncture, single transseptal puncture approach using PFA and vascular closure device resulted in a 100% rate of acute PVI and an extraordinarily fast procedure and time to ambulation. The rate of periprocedural complications was low.
Pulsed field ablation (PFA) is a non-thermal energy source with promising safety and efficacy advantages. We aimed to develop a convenient, safe, effective and fast method of pulmonary vein isolation (PVI) utilizing a penta-spline PFA catheter via a single femoral vein and a venous closure system. Consecutive patients (n=50; mean age: 63.6±10.7 years, 38% female) presenting with AF (paroxysmal AF: 56%) underwent first-time PVI via PFA. A single ultrasound-guided femoral vein puncture and a single transseptal puncture were used. After PVI using the penta-spline PFA catheter, extra pulse trains were added to the posterior wall for wide antral circumferential ablation. A venous closure system was used and a Donati suture was performed. The pressure bandage was removed after 1 h. A total of 196 PVs were identified and isolated with PFA only. The mean procedural time was 27.4±6.6 min, and the mean dwelling time was 14.4±5.5 min. Time to ambulation was 3.3±3.1 h. No severe complications occurred. During a mean follow-up of 6.5±2.1 months, 41/50 patients (82%) remained in sinus rhythm. The combination of a single venous puncture, single transseptal puncture approach using PFA and vascular closure device resulted in a 100% rate of acute PVI and an extraordinarily fast procedure and time to ambulation. The rate of periprocedural complications was low.
Pulsed field ablation (PFA) is a non-thermal energy source with promising safety and efficacy advantages. We aimed to develop a convenient, safe, effective and fast method of pulmonary vein isolation (PVI) utilizing a penta-spline PFA catheter via a single femoral vein and a venous closure system.BACKGROUNDPulsed field ablation (PFA) is a non-thermal energy source with promising safety and efficacy advantages. We aimed to develop a convenient, safe, effective and fast method of pulmonary vein isolation (PVI) utilizing a penta-spline PFA catheter via a single femoral vein and a venous closure system.Consecutive patients (n=50; mean age: 63.6±10.7 years, 38% female) presenting with AF (paroxysmal AF: 56%) underwent first-time PVI via PFA. A single ultrasound-guided femoral vein puncture and a single transseptal puncture were used. After PVI using the penta-spline PFA catheter, extra pulse trains were added to the posterior wall for wide antral circumferential ablation. A venous closure system was used and a Donati suture was performed. The pressure bandage was removed after 1 h. A total of 196 PVs were identified and isolated with PFA only. The mean procedural time was 27.4±6.6 min, and the mean dwelling time was 14.4±5.5 min. Time to ambulation was 3.3±3.1 h. No severe complications occurred. During a mean follow-up of 6.5±2.1 months, 41/50 patients (82%) remained in sinus rhythm.METHODS AND RESULTSConsecutive patients (n=50; mean age: 63.6±10.7 years, 38% female) presenting with AF (paroxysmal AF: 56%) underwent first-time PVI via PFA. A single ultrasound-guided femoral vein puncture and a single transseptal puncture were used. After PVI using the penta-spline PFA catheter, extra pulse trains were added to the posterior wall for wide antral circumferential ablation. A venous closure system was used and a Donati suture was performed. The pressure bandage was removed after 1 h. A total of 196 PVs were identified and isolated with PFA only. The mean procedural time was 27.4±6.6 min, and the mean dwelling time was 14.4±5.5 min. Time to ambulation was 3.3±3.1 h. No severe complications occurred. During a mean follow-up of 6.5±2.1 months, 41/50 patients (82%) remained in sinus rhythm.The combination of a single venous puncture, single transseptal puncture approach using PFA and vascular closure device resulted in a 100% rate of acute PVI and an extraordinarily fast procedure and time to ambulation. The rate of periprocedural complications was low.CONCLUSIONSThe combination of a single venous puncture, single transseptal puncture approach using PFA and vascular closure device resulted in a 100% rate of acute PVI and an extraordinarily fast procedure and time to ambulation. The rate of periprocedural complications was low.
ArticleNumber CJ-23-0389
Author Hatahet, Sascha
Große, Niels
Subin, Behnam
Kuck, Karl-Heinz
Kirstein, Bettina
Lopez, Lisbeth Delgado
Tilz, Roland R.
Phan, Huong-Lan
Heeger, Christian-H.
Eitel, Charlotte
Popescu, Sorin Ștefan
Vogler, Julia
Author_xml – sequence: 1
  fullname: Vogler, Julia
  organization: Department of Rhythmology, University Heart Center Lübeck, University Hospital Schleswig-Holstein
– sequence: 1
  fullname: Kuck, Karl-Heinz
  organization: Department of Rhythmology, University Heart Center Lübeck, University Hospital Schleswig-Holstein
– sequence: 1
  fullname: Tilz, Roland R.
  organization: German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck
– sequence: 1
  fullname: Popescu, Sorin Ștefan
  organization: Department of Rhythmology, University Heart Center Lübeck, University Hospital Schleswig-Holstein
– sequence: 1
  fullname: Kirstein, Bettina
  organization: Department of Rhythmology, University Heart Center Lübeck, University Hospital Schleswig-Holstein
– sequence: 1
  fullname: Eitel, Charlotte
  organization: Department of Rhythmology, University Heart Center Lübeck, University Hospital Schleswig-Holstein
– sequence: 1
  fullname: Phan, Huong-Lan
  organization: Department of Rhythmology, University Heart Center Lübeck, University Hospital Schleswig-Holstein
– sequence: 1
  fullname: Lopez, Lisbeth Delgado
  organization: Department of Rhythmology, University Heart Center Lübeck, University Hospital Schleswig-Holstein
– sequence: 1
  fullname: Hatahet, Sascha
  organization: Department of Rhythmology, University Heart Center Lübeck, University Hospital Schleswig-Holstein
– sequence: 1
  fullname: Heeger, Christian-H.
  organization: German Center for Cardiovascular Research (DZHK), Partner Site Hamburg/Kiel/Lübeck
– sequence: 1
  fullname: Große, Niels
  organization: Department of Rhythmology, University Heart Center Lübeck, University Hospital Schleswig-Holstein
– sequence: 1
  fullname: Subin, Behnam
  organization: Department of Rhythmology, University Heart Center Lübeck, University Hospital Schleswig-Holstein
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37532529$$D View this record in MEDLINE/PubMed
BookMark eNp9kcluFDEQhi0URBa4c0I-cung9tbtYzPKhESRiDQJV6va7c541Mtguw-5zTsgXhBeBM9GJA5cbFfV_5VLf52jk2EcLELvc3KZU8E-GefN6nJ2m1GWEVaqV-gsZ7zIeEnJye4tM1VydorOQ1gRQhUR6g06ZYVgVFB1hn7cT12wDZ472zW4qjuIbhyyz7BNplo_DuCf8TfrBnwTxn0ZPwY3PGHAC9evO9e6pF2kTGezyhgbwjGaQVzaaD2u1ms_gln-3mx-bX7ih6XFcwgRw5C-nrwbp4Dv5xVexKl5fotet5Cmene4L9Dj_Oph9iW7-3p9M6vuMiNpHrOmLYRgghMlDWvqXJVFUUOrGsq5EUAMl6a2pWpNoRpeAvBcWkVA5opyA5JdoI_7vmm275MNUfcuGNt1MNg0kKYlF1LIvCyS9MNBOtW9bfTauz75oo9GJoHcC4wfQ_C21cbFnVnRg-t0TvR2Y3q3MT271ZTp7cYSSP4Bj73_g1zvkVWI8GT_AuCjM509AGWR8O35Qr4oluC1Hdgfie62TA
CitedBy_id crossref_primary_10_1007_s10840_023_01664_z
crossref_primary_10_1016_j_hrthm_2024_09_060
crossref_primary_10_1111_jce_16411
crossref_primary_10_4103_IJHR_IJHR_3_23
crossref_primary_10_1093_ehjdh_ztae013
crossref_primary_10_1111_jce_16113
crossref_primary_10_3390_biomedicines12102375
crossref_primary_10_1002_joa3_70011
crossref_primary_10_3390_jcm13113113
crossref_primary_10_1007_s00399_025_01071_z
crossref_primary_10_1093_europace_euae105
crossref_primary_10_1016_j_jacasi_2024_09_014
crossref_primary_10_1253_circj_CJ_24_0859
crossref_primary_10_3390_medicina60050817
crossref_primary_10_1253_circj_CJ_23_0596
crossref_primary_10_31083_j_rcm2511415
Cites_doi 10.1161/CIRCEP.121.010817
10.1093/eurheartj/ehab648
10.1093/europace/euac050
10.1161/CIRCEP.119.007781
10.1161/CIRCEP.121.010516
10.1093/europace/euad022
10.1161/CIRCEP.122.011547
10.1093/eurheartj/ehad250
10.1016/j.jacc.2019.04.021
10.1007/s10840-023-01510-2
10.1093/europace/eux175
10.1093/europace/euac053.234
10.1093/europace/euac111
10.1016/j.ipej.2022.01.005
10.1161/CIRCULATIONAHA.119.042622
10.1093/europace/euac053.058
10.1016/j.hrthm.2022.03.488
10.1007/s12181-017-0179-4
10.1016/j.ijcha.2020.100576
10.1016/j.jacep.2021.02.014
ContentType Journal Article
Copyright 2023, THE JAPANESE CIRCULATION SOCIETY
Copyright_xml – notice: 2023, THE JAPANESE CIRCULATION SOCIETY
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1253/circj.CJ-23-0389
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1347-4820
EndPage 1726
ExternalDocumentID 37532529
10_1253_circj_CJ_23_0389
article_circj_87_12_87_CJ_23_0389_article_char_en
Genre Journal Article
GroupedDBID ---
.55
29B
2WC
53G
5GY
5RE
6J9
ACGFO
ADBBV
AENEX
ALMA_UNASSIGNED_HOLDINGS
BAWUL
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
GX1
JSF
JSH
KQ8
OK1
OVT
P2P
RJT
RNS
RZJ
TR2
W2D
X7M
XSB
ZXP
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
M~E
NPM
7X8
ID FETCH-LOGICAL-c621t-df755354096c3db19877baf9d244c5a0c46cbe89fc79d48aa416e90a61924ca63
ISSN 1346-9843
1347-4820
IngestDate Fri Jul 11 04:36:13 EDT 2025
Wed Jan 22 16:37:07 EST 2025
Thu Apr 24 22:59:31 EDT 2025
Tue Jul 01 02:01:35 EDT 2025
Wed Sep 03 06:31:09 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords Pulse field ablation
Venous closure system
Atrial fibrillation
Acute efficacy
Pulmonary vein isolation
Language English
License https://creativecommons.org/licenses/by-nc-nd/4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c621t-df755354096c3db19877baf9d244c5a0c46cbe89fc79d48aa416e90a61924ca63
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.jstage.jst.go.jp/article/circj/87/12/87_CJ-23-0389/_article/-char/en
PMID 37532529
PQID 2845656187
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_2845656187
pubmed_primary_37532529
crossref_citationtrail_10_1253_circj_CJ_23_0389
crossref_primary_10_1253_circj_CJ_23_0389
jstage_primary_article_circj_87_12_87_CJ_23_0389_article_char_en
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-11-24
PublicationDateYYYYMMDD 2023-11-24
PublicationDate_xml – month: 11
  year: 2023
  text: 2023-11-24
  day: 24
PublicationDecade 2020
PublicationPlace Japan
PublicationPlace_xml – name: Japan
PublicationTitle Circulation Journal
PublicationTitleAlternate Circ J
PublicationYear 2023
Publisher The Japanese Circulation Society
Publisher_xml – name: The Japanese Circulation Society
References 14. Nentwich K, Ene EE, Berkowitz AB, Simu GS, Sonne KS, Mueller JM, et al. Acute safety and efficacy outcome of pulmonary vein isolation using pulsed field ablation technology. EP Europace 2022; 24(Suppl 1): euac053.058, doi:10.1093/europace/euac053.058.
8. Heeger CH, Tilz RR. Pulsed-field ablation: Are we ready for fast and furious atrial tachycardia ablation? J Interv Card Electrophysiol 2023, doi:10.1007/s10840-023-01510-2.
10. Tilz RR, Chun KRJ, Deneke T, Kelm M, Piorkowski C, Sommer P, et al. Positionspapier der Deutschen Gesellschaft für Kardiologie zur Kardioanalgosedierung. Der Kardiologe 2017; 11: 369–382 (in German).
12. Füting A, Reinsch N, Brokkaar L, Hartl S, Höwel D, Essling A, et al. Bronchial safety after pulsed field ablation for paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol 2023; 16: e011547.
16. Koruth J, Kuroki K, Iwasawa J, Enomoto Y, Viswanathan R, Brose R, et al. Preclinical evaluation of pulsed field ablation: Electrophysiological and histological assessment of thoracic vein isolation. Circ Arrhythm Electrophysiol 2019; 12: e007781.
2. Fabbricatore D, Buytaert D, Valeriano C, Mileva N, Paolisso P, Nagumo S, et al. Ambulatory pulmonary vein isolation workflow using the Perclose ProglideTM suture-mediated vascular closure device: The PRO-PVI study. Europace 2023; 25: 1361–1368.
5. Tilz RR, Schmidt V, Pürerfellner H, Maury P, Chun KJ, Martinek M, et al. A worldwide survey on incidence, management and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: The POTTER-AF study. Eur Heart J 2023; 44: 2458–2469.
6. Ekanem E, Reddy VY, Schmidt B, Reichlin T, Neven K, Metzner A, et al. Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF). Europace 2022; 24: 1256–1266.
1. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2020; 42: 373–498.
18. Gunawardene M, Schaeffer B, Eickholt C, Hartmann J, Anwar O, Gessler N, et al. PO-679-04 pulsed field ablation combined with ultra-high-density mapping in patients undergoing catheter ablation for atrial fibrillation. Heart Rhythm 2022; 19(Suppl): S354.
9. Andrade JG, Champagne J, Dubuc M, Deyell MW, Verma A, Macle L, et al. Cryoballoon or radiofrequency ablation for atrial fibrillation assessed by continuous monitoring. Circulation 2019; 140: 1779–1788.
15. Bohnen M, Weber R, Minners J, Jadidi A, Eichenlaub M, Neumann FJ, et al. Characterization of circumferential antral pulmonary vein isolation areas resulting from pulsed-field catheter ablation. Europace 2022; 25: 65–73.
7. Schmidt B, Bordignon S, Tohoku S, Chen S, Bologna F, Urbanek L, et al. 5S Study: Safe and simple single shot pulmonary vein isolation with pulsed field ablation using sedation. Circ Arrhythm Electrophysiol 2022; 15: e010817.
13. Winkelmann SJ, Lemoine MD, Wuerger T, Schleberger R, Rottner L, Dinshaw L, et al. Safety of pulsed-field ablation in patients with cardiac implantable electronic devices: A single-center pilot study. EP Europace 2022; 24(Suppl 1): euac053.234, doi:10.1093/europace/euac053.234.
11. Reddy VY, Neuzil P, Koruth JS, Petru J, Funosako M, Cochet H, et al. Pulsed field ablation for pulmonary vein isolation in atrial fibrillation. J Am Coll Cardiol 2019; 74: 315–326.
4. Heeger CH, Tiemeyer CM, Phan HL, Meyer-Saraei R, Fink T, Sciacca V, et al. Rapid pulmonary vein isolation utilizing the third-generation laserballoon: The PhoeniX registry. Int J Cardiol Heart Vasc 2020; 29: 100576.
17. Reddy VY, Dukkipati SR, Neuzil P, Anic A, Petru J, Funasako M, et al. Pulsed field ablation of paroxysmal atrial fibrillation: 1-year outcomes of IMPULSE, PEFCAT, and PEFCAT II. JACC Clin Electrophysiol 2021; 7: 614–627.
19. Triantafyllou K, Karkos CD, Fragakis N, Antoniadis AP, Meletidou M, Vassilikos V. Ultrasound-guided versus anatomic landmark-guided vascular access in cardiac electrophysiology procedures: A systematic review and meta-analysis. Indian Pacing Electrophysiol J 2022; 22: 145–153.
3. Heeger CH, Sohns C, Pott A, Metzner A, Inaba O, Straube F, et al. Phrenic nerve injury during cryoballoon-based pulmonary vein isolation: RESULTS of the worldwide YETI registry. Circ Arrhythm Electrophysiol 2022; 15: e010516.
20. Yamagata K, Wichterle D, Roubícek T, Jarkovský P, Sato Y, Kogure T, et al. Ultrasound-guided versus conventional femoral venipuncture for catheter ablation of atrial fibrillation: A multicentre randomized efficacy and safety trial (ULTRA-FAST trial). Europace 2017; 20: 1107–1114.
11
12
13
14
15
16
17
18
19
1
2
3
4
5
6
7
8
9
20
10
37730372 - Circ J. 2023 Nov 24;87(12):1727-1729. doi: 10.1253/circj.CJ-23-0596
References_xml – reference: 4. Heeger CH, Tiemeyer CM, Phan HL, Meyer-Saraei R, Fink T, Sciacca V, et al. Rapid pulmonary vein isolation utilizing the third-generation laserballoon: The PhoeniX registry. Int J Cardiol Heart Vasc 2020; 29: 100576.
– reference: 14. Nentwich K, Ene EE, Berkowitz AB, Simu GS, Sonne KS, Mueller JM, et al. Acute safety and efficacy outcome of pulmonary vein isolation using pulsed field ablation technology. EP Europace 2022; 24(Suppl 1): euac053.058, doi:10.1093/europace/euac053.058.
– reference: 1. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2020; 42: 373–498.
– reference: 20. Yamagata K, Wichterle D, Roubícek T, Jarkovský P, Sato Y, Kogure T, et al. Ultrasound-guided versus conventional femoral venipuncture for catheter ablation of atrial fibrillation: A multicentre randomized efficacy and safety trial (ULTRA-FAST trial). Europace 2017; 20: 1107–1114.
– reference: 13. Winkelmann SJ, Lemoine MD, Wuerger T, Schleberger R, Rottner L, Dinshaw L, et al. Safety of pulsed-field ablation in patients with cardiac implantable electronic devices: A single-center pilot study. EP Europace 2022; 24(Suppl 1): euac053.234, doi:10.1093/europace/euac053.234.
– reference: 10. Tilz RR, Chun KRJ, Deneke T, Kelm M, Piorkowski C, Sommer P, et al. Positionspapier der Deutschen Gesellschaft für Kardiologie zur Kardioanalgosedierung. Der Kardiologe 2017; 11: 369–382 (in German).
– reference: 11. Reddy VY, Neuzil P, Koruth JS, Petru J, Funosako M, Cochet H, et al. Pulsed field ablation for pulmonary vein isolation in atrial fibrillation. J Am Coll Cardiol 2019; 74: 315–326.
– reference: 5. Tilz RR, Schmidt V, Pürerfellner H, Maury P, Chun KJ, Martinek M, et al. A worldwide survey on incidence, management and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: The POTTER-AF study. Eur Heart J 2023; 44: 2458–2469.
– reference: 8. Heeger CH, Tilz RR. Pulsed-field ablation: Are we ready for fast and furious atrial tachycardia ablation? J Interv Card Electrophysiol 2023, doi:10.1007/s10840-023-01510-2.
– reference: 2. Fabbricatore D, Buytaert D, Valeriano C, Mileva N, Paolisso P, Nagumo S, et al. Ambulatory pulmonary vein isolation workflow using the Perclose ProglideTM suture-mediated vascular closure device: The PRO-PVI study. Europace 2023; 25: 1361–1368.
– reference: 15. Bohnen M, Weber R, Minners J, Jadidi A, Eichenlaub M, Neumann FJ, et al. Characterization of circumferential antral pulmonary vein isolation areas resulting from pulsed-field catheter ablation. Europace 2022; 25: 65–73.
– reference: 17. Reddy VY, Dukkipati SR, Neuzil P, Anic A, Petru J, Funasako M, et al. Pulsed field ablation of paroxysmal atrial fibrillation: 1-year outcomes of IMPULSE, PEFCAT, and PEFCAT II. JACC Clin Electrophysiol 2021; 7: 614–627.
– reference: 18. Gunawardene M, Schaeffer B, Eickholt C, Hartmann J, Anwar O, Gessler N, et al. PO-679-04 pulsed field ablation combined with ultra-high-density mapping in patients undergoing catheter ablation for atrial fibrillation. Heart Rhythm 2022; 19(Suppl): S354.
– reference: 9. Andrade JG, Champagne J, Dubuc M, Deyell MW, Verma A, Macle L, et al. Cryoballoon or radiofrequency ablation for atrial fibrillation assessed by continuous monitoring. Circulation 2019; 140: 1779–1788.
– reference: 12. Füting A, Reinsch N, Brokkaar L, Hartl S, Höwel D, Essling A, et al. Bronchial safety after pulsed field ablation for paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol 2023; 16: e011547.
– reference: 19. Triantafyllou K, Karkos CD, Fragakis N, Antoniadis AP, Meletidou M, Vassilikos V. Ultrasound-guided versus anatomic landmark-guided vascular access in cardiac electrophysiology procedures: A systematic review and meta-analysis. Indian Pacing Electrophysiol J 2022; 22: 145–153.
– reference: 7. Schmidt B, Bordignon S, Tohoku S, Chen S, Bologna F, Urbanek L, et al. 5S Study: Safe and simple single shot pulmonary vein isolation with pulsed field ablation using sedation. Circ Arrhythm Electrophysiol 2022; 15: e010817.
– reference: 16. Koruth J, Kuroki K, Iwasawa J, Enomoto Y, Viswanathan R, Brose R, et al. Preclinical evaluation of pulsed field ablation: Electrophysiological and histological assessment of thoracic vein isolation. Circ Arrhythm Electrophysiol 2019; 12: e007781.
– reference: 3. Heeger CH, Sohns C, Pott A, Metzner A, Inaba O, Straube F, et al. Phrenic nerve injury during cryoballoon-based pulmonary vein isolation: RESULTS of the worldwide YETI registry. Circ Arrhythm Electrophysiol 2022; 15: e010516.
– reference: 6. Ekanem E, Reddy VY, Schmidt B, Reichlin T, Neven K, Metzner A, et al. Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF). Europace 2022; 24: 1256–1266.
– ident: 7
  doi: 10.1161/CIRCEP.121.010817
– ident: 1
  doi: 10.1093/eurheartj/ehab648
– ident: 6
  doi: 10.1093/europace/euac050
– ident: 16
  doi: 10.1161/CIRCEP.119.007781
– ident: 3
  doi: 10.1161/CIRCEP.121.010516
– ident: 2
  doi: 10.1093/europace/euad022
– ident: 12
  doi: 10.1161/CIRCEP.122.011547
– ident: 5
  doi: 10.1093/eurheartj/ehad250
– ident: 11
  doi: 10.1016/j.jacc.2019.04.021
– ident: 8
  doi: 10.1007/s10840-023-01510-2
– ident: 20
  doi: 10.1093/europace/eux175
– ident: 13
  doi: 10.1093/europace/euac053.234
– ident: 15
  doi: 10.1093/europace/euac111
– ident: 19
  doi: 10.1016/j.ipej.2022.01.005
– ident: 9
  doi: 10.1161/CIRCULATIONAHA.119.042622
– ident: 14
  doi: 10.1093/europace/euac053.058
– ident: 18
  doi: 10.1016/j.hrthm.2022.03.488
– ident: 10
  doi: 10.1007/s12181-017-0179-4
– ident: 4
  doi: 10.1016/j.ijcha.2020.100576
– ident: 17
  doi: 10.1016/j.jacep.2021.02.014
– reference: 37730372 - Circ J. 2023 Nov 24;87(12):1727-1729. doi: 10.1253/circj.CJ-23-0596
SSID ssj0029059
Score 2.463924
Snippet Background: Pulsed field ablation (PFA) is a non-thermal energy source with promising safety and efficacy advantages. We aimed to develop a convenient, safe,...
Pulsed field ablation (PFA) is a non-thermal energy source with promising safety and efficacy advantages. We aimed to develop a convenient, safe, effective and...
SourceID proquest
pubmed
crossref
jstage
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1722
SubjectTerms Acute efficacy
Aged
Atrial fibrillation
Atrial Fibrillation - surgery
Catheter Ablation - methods
Catheters
Female
Humans
Male
Middle Aged
Pulmonary vein isolation
Pulmonary Veins - surgery
Pulse field ablation
Treatment Outcome
Venous closure system
Title Pulsed Field Ablation-Based Pulmonary Vein Isolation Using a Simplified Single-Access Single-Catheter Approach ― The Fast and Furious PFA Study
URI https://www.jstage.jst.go.jp/article/circj/87/12/87_CJ-23-0389/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/37532529
https://www.proquest.com/docview/2845656187
Volume 87
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Circulation Journal, 2023/11/24, Vol.87(12), pp.1722-1726
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELZCQVUvFW9SHjISHFDkdON930ijhBJUVKkP5bayvU6VKiRVSC499S_w77jzR5ixvU5SNQi4rBI_1rs739oz3m9mCHnHVZmmZRqzuDUULMojwTIdBUzlQclBH9e58fA--pocnkX9QTyo1X6usJYWc9lU13f6lfyPVKEM5Ipesv8gWX9SKIDfIF84goTh-FcyPl7AwlY2eshCa7SlpbWxA4GFUAfXgZy4cz2aND7DlVhZW5KAaJyMkEw-RBX0BErGmrVN8sTqn_ENxBCKbRd2_H03RF5EFjDD0-iJ75ad3lvMDJH2uNc2tMS1D8Wd0Uy5DGE-SsWm0BWoA_dh8cakmI3Vjo5a6ncZRuNrywofG_fKqvx8euH8GtHr2683X0ag4bqcngcaed6-qgsK99izDqYV68ntgvAQ3QGt83VT25k7jFIWZTxYndrdWu4gzFcmatDb-J0rCDdpQBTc42Wz02cwEoYgXG0KD-nqm0FUCLYej92OzXrU7qrqHrnPwYDB3BqfBp58xHPQat1Hcxhw__ZwO2S7OsGavvTgEkyGC73ZGjJa0elDsuvMGdq22HxEanrymGwfOcLGE_LDQpQaiNJ1iFIPUYoQpR6i1ECUCrqEKF2DKL0FUVpB9NfNDaMATorgpAAO6sBJAZzUgPMpOet1TzuHzGUBYSrhrTkrh2kc4-5knqiwlLhJlkoxzEtQTFUsAhUlSuosH6o0L6NMCDAxdB4Is7WgRBI-I1uT6US_IJS3pBa8BTZEriJeJkJyXsYyl6KUAde8TvarZ10oFyIfM7WMCzSVQVCFEVTR6Rc8LFBQdfLB97iy4WH-0PajFZ9v6SYO1zJLoR8el12WLeAtgBmvTt5Wgi9gGcBve_BOwlMsQMtE06yVpXXy3CLCD1NBaW9jzUuys3ypXpGt-WyhX4OyPZdvDG5_A21H2c4
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pulsed+Field+Ablation-Based+Pulmonary+Vein+Isolation+Using+a+Simplified+Single-Access+Single-Catheter+Approach%E3%80%80-+The+Fast+and+Furious+PFA+Study&rft.jtitle=Circulation+journal+%3A+official+journal+of+the+Japanese+Circulation+Society&rft.au=Tilz%2C+Roland+R&rft.au=Vogler%2C+Julia&rft.au=Kirstein%2C+Bettina&rft.au=Eitel%2C+Charlotte&rft.date=2023-11-24&rft.eissn=1347-4820&rft.volume=87&rft.issue=12&rft.spage=1722&rft_id=info:doi/10.1253%2Fcircj.CJ-23-0389&rft_id=info%3Apmid%2F37532529&rft.externalDocID=37532529
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1346-9843&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1346-9843&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1346-9843&client=summon